|
|
|
| How AI-Enabled Digital Validation Technologies Enable the Predictive Plant | As life sciences manufacturers advance digital maturity, validation data is evolving from a compliance artifact into a strategic asset. This CAI webinar explores how second-generation, AI-enabled Digital Validation Technologies transform document-centric validation into predictive lifecycle intelligence. Learn how integrated DVT platforms enable real-time asset visibility, proactive risk identification, and data-driven decision-making across facilities, supporting operations and a predictive plant model. Click here to learn more. |
|
|
|
|
|
| Dynamic Precision Weighing Challenges And Innovations | White Paper | Mettler-Toledo Product Inspection | Effective precision weighing systems enable users to balance product throughput, center distance, and standard deviation. Explore key considerations in this technology's development and weighing methods. |
|
|
|
|
By Katie Anderson, chief editor, Pharmaceutical Online | What does a production facility of the future look like? That’s exactly what Bayer management asked its team before planning began for the world’s most modern pharmaceutical facility, Solida 1. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| High-Content Imaging Drives Protein Degraders From Hit To Lead | Poster | By Clark Driscoll, Erin Olin, Adam McCabe, et al., Curia | Uncover a cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system to efficiently identify small molecule protein degraders with rich, multi-dimensional data. |
|
|
|
|
|
|
|
| New Vs. Used Processing Equipment: A Cost Comparison | Article | Federal Equipment Company | For pharmaceutical and chemical manufacturers, balancing budgets with operational needs is crucial. Find out how sourcing used equipment offers significant cost advantages over new. |
|
|
|
|
|
| The 4th Nasal Formulation & Delivery Summit is uniting formulation, delivery, and product development leaders to advance the development of safe, effective, and commercially viable intranasal therapies. Join 70+ experts from Eli Lilly, Bayer, Neurelis, Virpax Pharmaceuticals, Belhaven Biopharma, and more to explore real-world preclinical and clinical data, compare liquid and powder nasal approaches, and align on best practices for systemic and nose-to-brain delivery. |
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|